课题基金 / 基金详情

Efficacy, Tolerability, and Safety of Maintenance Ketamine Infusions for Treatment-Resistant Bipolar Disorder: An Open-Label Extension Trial

Efficacy, Tolerability, and Safety of Maintenance Ketamine Infusions for Treatment-Resistant Bipolar Disorder: An Open-Label Extension Trial
维持氯胺酮输注治疗难治性双相情感障碍的功效、耐受性和安全性：一项开放标签延伸试验
批准号：
486405
负责人：
Haikazian Sipan
金额：
$1.27万
依托单位：
University of Toronto
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2022
资助国家：
加拿大
项目状态：
已结题
起止时间：
2022-12-01 至 2023-12-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=486405&lang=en
关键词：
Bipolar Depression Glutamatergic Agent Ketamine Mental Disorders Open-Label Trial

项目摘要

项目成果

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Bipolar depression (BD) is a debilitating mental illness associated with depressed mood, suicidal ideation, and functional impairment. Around one-quarter to one-third of patients with BD who do not respond to commonly prescribed antidepressants are diagno
期刊论文(0)
专著(0)
科研奖励(0)
会议论文